Application 204029
- Type
- ANDA
- Sponsor
- ABON PHARMS LLC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CLOFARABINE | CLOFARABINE | SOLUTION;INTRAVENOUS | 20MG/20ML (1MG/ML) | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 49315-003 | CLOFARABINE | clofarabine | Cadila Healthcare Limited | ANDA | Current |
| 49315-003 | CLOFARABINE | clofarabine | Zydus Lifesciences Limited | ANDA | Current |
| 63323-572 | CLOFARABINE | clofarabine | Fresenius-Kabi | ANDA | Current |
| 63323-572 | CLOFARABINE | clofarabine | Fresenius Kabi USA, LLC | ANDA | Current |
| 63323-572 | CLOFARABINE | clofarabine | Fresenius-Kabi | ANDA | Current |